v3.23.1
Summary of Components of Deferred Tax Assets (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]    
Net operating loss carryforwards $ 11,557 $ 10,836
Capitalized research and development expenses 4,460
Research and development credit carryforwards 698 12
Capitalized start-up expenses 293 432
Stock-based compensation 860 815
Lease liability 234 625
Other 2,206 2,415
Total deferred tax assets 20,308 15,135
Right-of-use-asset (194) (572)
Total deferred tax liabilities (194) (572)
Valuation allowance (20,114) (14,563)
Net deferred tax liabilities